Annual Declaration of Compliance
Declaration of Compliance for 2017
Meda Pharmaceuticals Inc. on behalf of itself and its subsidiaries, Acton Pharmaceuticals Inc. and Alaven Pharmaceuticals LLC (collectively "Meda") declares to the best of its knowledge and based upon a good faith understanding of the statutory requirements, that it has established a comprehensive compliance program that meets the requirements of the California Health and Safety Code, sections 119400-119402. Meda declares that it is, in all material respects, in compliance with its compliance program and the California Health and Safety Code, sections 119400-119402. Meda will review its program at least annually. Through this review, Meda will continue its efforts to address the issues raised by the California law and to enhance the effectiveness of the program as needed to maintain a program that is reasonably designed to prevent or to detect and address violations of law or company policy.